Understanding Your Mesothelioma Treatment Options

Summary:

• Every year, approximately 3,000 people are affected by mesothelioma, mostly due to asbestos exposure, a slow cancer to diagnose.

• An Alabama mesothelioma lawyer can assist in uncovering exposure history while focusing on medical treatment.

• Treatment options vary based on cancer location, extent, subtype, and patient health status, with surgery, chemotherapy, radiation, immunotherapy, and targeted therapy available.

Every year, approximately 3,000 people are affected by mesothelioma, which is an uncommon and mostly advanced cancer that occurs within the United States. Sources vary, but asbestos-related exposure is seen to contribute to most of them. Mesothelioma is a slow disease that takes years to diagnose.

Because the disease is so closely tied to a specific, identifiable cause, many patients find it worthwhile to look into where their exposure may have happened alongside pursuing treatment. An Alabama mesothelioma lawyer can help someone in that state work through this history while medical care remains the immediate priority.

Mesothelioma symptoms include tightness in the chest, difficulty in breathing, and swelling in the abdomen. And when patients recognize these, the disease may already have gone too far for initial prevention and control. Treatment may very well be unavailable in the majority of cases. But knowing the proper disease management can extend life, relieve symptoms, and improve life quality.

What Treatment Depends On

Mesothelioma treatment options depend on several factors. Where is the specific location of the cancer? What is the extent of disease within the body? What is its histological subtype and the health status of the patient?

The most common form of mesothelioma is pleural mesothelioma. This type affects the lining of the lung. Another less common term variant is peritoneal mesothelioma, which affects the lining of the abdomen. This type follows the same treatment logic as the other types of mesothelioma.

An important aspect when considering a form of treatment is the resectability of the cancer. Resectability refers to whether or not the cancer can be eliminated through an operation by excising all the tumor. Epithelioid cancer has a better response to surgery compared to sarcomatoid cancer.

The treatment of mesothelioma is challenging given the rarity of the disease and the numerous gray areas that are associated with it. Mesothelioma treatment requires a team skilled in rendering its services, especially at a comprehensive cancer care center, rather than a single health care provider managing a mesothelioma patient.

Surgery

In the case of pleural mesothelioma diagnosed at an early stage so that it can be resected, there are two major surgical treatments that are currently provided and used. These treatments are pleurectomy/decortication and extrapleural pneumonectomy. Pleurectomy or decortication procedures entail removing the pleura while leaving the lung untouched. Extrapleural pneumonectomy is more aggressive and involves removing the lung and surrounding tissues.

Cytoreductive surgery, more commonly referred to as debulking, with hyperthermic chemotherapy administered early in the same procedure, is the standard treatment for peritoneal mesothelioma.

Surgery on its own is seldomly justified. Usually, it is performed together with chemotherapy or radiation therapy. These treatments are performed before surgery or after surgery based on a patient’s treatment regimen.

Chemotherapy and radiation

One of the primary treatments is chemotherapy, mainly used when surgery is not deemed effective for mesothelioma. It causes the tumors to shrink down, reduces the advancements of the cancer to some extent, and mitigates mesothelioma symptoms. The individual undergoing chemotherapy will experience side effects, some of which include tiredness, throwing up, and loss of hair.

Usually, radiation treatment is added to either surgical intervention or chemotherapeutic treatment to curb local symptoms by focusing on a specific site.

Immunotherapy and targeted therapy

The medical experts recommended immunotherapy as an important part of treatment for mesothelioma care in recent years. The treatment works by enhancing the body’s defenses against cancer and attacking the cancer cells. When surgical treatment is not a viable possibility for cancer, immunotherapy is more commonly used as the primary treatment, either as a stand-alone or in combination with chemotherapy.

Targeted therapies are also a viable option depending on the patient. They seek out and disable particular cellular abnormalities in carcinoma. For example, chemotherapy agents destroy every cell that grows relatively fast, whereas targeted therapy drugs only suppress the growth of cells that have a particular marker.

Tumor Treating Fields

One newer approach uses a wearable device that creates electric fields designed to disrupt the division of cancer cells. Referred to as “Tumor Treating Fields,” this therapy is not meant to replace chemotherapy but rather be used alongside it. It is a relatively recent addition to the mainstream treatment regimen.

Palliative and supportive care

Symptom management remains a centerpiece of care regardless of the treatment combination chosen by the patient. Patients with mesothelioma usually experience a fluid-filled chest and abdomen. This symptom can be managed through methods that help get rid of the fluid in the chest or keep the fluid accumulation under control. Integral to this aspect are coping mechanisms with pain, supervising nutrition deficits, and providing both mental and physical health care to patients and families.

A mandatory aspect to understand is that all patients are unique, and as mesothelioma is not a common disease, every oncologist does not deal with such cases with frequency. In most situations, it is advisable to seek the opinion of another expert or institution, for instance, a cancer center, before starting the recommended treatment plan.

Participating in clinical tests may be worth it. These experiments allow a patient to access the advanced medications not yet available in standard cancer treatment.

None of these treatments cure mesothelioma, but that isn’t the same as saying nothing can be done. The right combination, chosen with a care team experienced in this specific disease, can meaningfully extend both the length and the quality of the time that follows a diagnosis.